Differences and similarities regarding adiponectin investigated in African and Caucasian women

European Journal of Endocrinology

Volumn 157, Issue 2, 2007, Pages 181-188

  Schutte, Aletta E ^b   Huisman, Hugo W ^b   Schutte, Rudolph ^b   Malan, Leoné ^b   van Rooyen, Johannes M ^b   Malan, Nico T ^b   Schwarz, Peter E H ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b NORTH WEST UNIVERSITY   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; C PEPTIDE; GLUCOSE; INSULIN; LEPTIN; LIPID; TRIACYLGLYCEROL;

ADULT; ARTERY COMPLIANCE; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD SAMPLING; BODY HEIGHT; BODY MASS; BODY WEIGHT; CAUCASIAN; CONTROLLED STUDY; DIET RESTRICTION; ETHNIC DIFFERENCE; FEMALE; HOMEOSTASIS; HUMAN; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; MULTIPLE REGRESSION; NEGRO; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL; URBAN POPULATION; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

ADIPONECTIN; ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; ANTHROPOMETRY; BLOOD PRESSURE; BODY MASS INDEX; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEART RATE; HUMANS; LEPTIN; LIPIDS; METABOLIC SYNDROME X; OBESITY; SOUTH AFRICA;

EID: 34547779380     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/EJE-07-0044     Document Type: Article

References (37)

1. Matsuzawa Y. Adiponectin: Identification, physiology and clinical relevance in metabolic and vascular disease. Atherosclerosis. Supplements 2005 6 7-14.
2. Okamoto Y, Kihara S, Ouchi N, Nishida M, Arita Y, Kumada M, Ohashi K, Sakai N, Shimomura I, Kobayashi H, Terasaka N, Inaba T, Funahashi T & Matsuzawa Y. Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice. Circulation 2002 106 2767-2770.
3. Ouchi N, Kihara S, Arita Y, Nishida M, Matsuyama A, Okamoto Y, Ishigami M, Kuriyama H, Kishida K, Nishizawa H, Hotta K, Muraguchi M, Ohmoto Y, Yamashita S, Funahashi T & Matsuzawa Y. Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages. Circulation 2001 103 1057-1063.
4. Stefan N, Stumvoll M, Vozarova B, Weyer C, Funahashi T, Matsuzawa Y, Bogardus C & Tataranni PA. Plasma adiponectin and endogenous glucose production in humans. Diabetes Care 2003 26 3315-3319.
5. Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S, Yamashita S, Noda M, Kita S, Ueki K, Eto K, Akanuma Y, Froguel P, Foufelle F, Ferre F, Carling D, Kimura S, Nagai R, Kahn BB & Kadowaki T. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nature Medicine 2002 8 1288-1295.
6. Maeda N, Shimomura I, Kishida K, Nishizawa H, Matsuda M, Nagaretani H, Furuyama N, Kondo H, Takahashi M, Arita Y, Komuro R, Ouchi N, Kihara S, Tochino Y, Okutomi K, Horie M, Takeda S, Aoyama T, Funahashi T & Matsuzawa Y. Diet-induced insulin resistance in mice lacking adiponectin/ ACRP30. Nature Medicine 2002 8 731-737.
7. Engeli S, Feldpausch M, Gorzelniak K, Hartwig G, Heintze U, Janke J, Mohlig M, Pfeiffer AFH, Luft FC & Sharma AM. Association between adiponectin and mediators of inflammation in obese women. Diabetes 2003 52 942-947.
8. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K, Kuriyama H, Nishida M, Yamashita S, Okubo K, Matsubara K, Muraguchi M, Ohmoto Y, Funahashi T & Matsuzawa Y. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochemical and Biophysical Research Communications 1999 257 79-83.
9. Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, Iwahashi H, Kuriyama H, Ouchi N, Maeda K, Nishida M, Kihara S, Sakai N, Nakajima T, Hasegawa K, Muraguchi M, Ohmoto Y, Nakamura T, Yamashita S, Hanafusa T & Matsuzawa Y. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arteriosclerosis, Thrombosis, and Vascular Biology 2000 20 1595-1599.
10. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE & Tataranni PA. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. Journal of Clinical Endocrinology and Metabolism 2001 86 1930-1935.
11. Hu F, Liang P & Spiegelman BM. AdipoQ is a novel adipose-specific gene dysregulated in obesity. Journal of Biological Chemistry 1996 271 10697-10703.
12. Ryan AS, Berman DM, Nicklas BJ, Sinha M, Gingerich RL, Meneilly GS, Egan JM & Elahi D. Plasma adiponectin and leptin levels, body composition, and glucose utilization in adult women with wide ranges of age and obesity. Diabetes Care 2003 26 2383-2388.
13. Lindsay RS, Funahashi T, Krakoff J, Matsuzawa Y, Tanaka S, Kobes S, Bennett PH, Tataranni PA, Knowler WC & Hanson RL. Genome-wide linkage analysis of serum adiponectin in the Pima Indian population. Diabetes 2003 52 2419-2425.
14. Menzaghi C, Ercolino T, Di PR, Berg AH, Warram. JH, Scherer PE, Trischitta V & Doria A. A haplotype at the adiponectin locus is associated with obesity and other features of the insulin resistance syndrome. Diabetes 2002 51 2306-2312.
15. Hulver MW, Saleh O, MacDonald KG, Pories WJ & Barakat HA. Ethnic differences in adiponectin levels. Metabolism 2004 53 1-3.
16. Opie LH & Seedat YK. Hypertension in sub-Saharan African populations. Circulation 2005 112 3562-3568.
17. Joffe BI, Wing JR, Zouvanis M, Pieterse A & Seftel HC. NIDDM in African-Americans and black South Africans: many similarities but some important differences. Diabetes Care 1996 19 1451-1452.
18. Puoane T, Steyn K, Bradshaw D, Laubscher R, Fourie J, Lambert V & Mbananga N. Obesity in South Africa: the South African demographic and health survey. Obesity Research 2002 10 1038-1048.
19. Deurenberg P, Andreoli A, Borg P, Kukkonen-Harjula K, de LA, van Marken Lichtenbelt WD, Testolin G, Vigano R & Vollaard. N. The validity of predicted body fat percentage from body mass index and from impedance in samples of five European populations. European Journal of Clinical Nutrition 2001 55 973-979.
20. Imholz BPM, Wieling W. van Montfrans GA & Wesseling KH. Fifteen years experience with finger arterial pressure monitoring: assessment of the technology. Cardiovascular Research 1998 38 605-616.
21. Schutte AE, Huisman HW. van Rooyen JM, Malan NT & Schutte R. Validation of the Finometer device for measurement of blood pressure in black women. Journal of Human Hypertension 2004 18 79-84.
22. Wesseling KH, Jansen JR, Settels JJ & Schreuder JJ. Computation of aortic flow from pressure in humans using a nonlinear, three-element model. Journal of Applied Physiology 1993 74 2566-2573.
23. Dart AM & Kingwell BA. Pulse pressure - a review of mechanisms and clinical relevance. Journal of the American College of Cardiology 2001 37 975-984.
24. Silke B & McAuley D. Accuracy and precision of blood pressure determination with the Finapres: an overview using re-sampling statistics. Journal of Human Hypertension 1998 12 403-409.
25. Langewouters GJ, Settels JJ, Roelandt R & Wesseling KH. Why use Finapres or Portapres rather than intra-arterial or intermittent non-invasive techniques of blood pressure measurement? Journal of Medical Engineering and Technology 1998 22 37-43.
26. Comuzzie AG, Funahashi T, Sonnenberg G, Martin LJ, Jacob HJ, Black AEK, Maas D, Takahashi M, Kihara S, Tanaka S, Matsuzawa Y, Blangero, J, Cohen D & Kissebah A. The genetic basis of plasma variation in adiponectin, a global endophenotype for obesity and the metabolic syndrome. Journal of Clinical Endocrinology and Metabolism 2001 86 4321-4325.
27. Stumvoll M, Tschritter O, Fritsche A, Staiger H, Renn W, Weisser M, Machicao F & Haring H. Association of the T-G polymorphism in adiponectin (exon 2) with obesity and insulin sensitivity: interaction with family history of type 2 diabetes. Diabetes 2002 51 37-41.
28. Kruger HS, Margetts BM & Vorster HH. Evidence for relatively greater subcutaneous fat deposition in stunted girls in the North West Province, South Africa, as compared with non-stunted girls. Nutrition 2004 20 564-569.
29. Kruger HS, Venter CS, Vorster HH & Margetts BM. Physical inactivity is the major determinant of obesity in black women in the North West Province, South Africa: the THUSA study. Nutrition 2002 18 422-427.
30. Kruger HS, Venter CS & Vorster HH. Obesity in African women in the North West Province, South Africa is associated with an increased risk of non-communicable diseases: the THUSA study. British Journal of Nutrition 2001 86 733-740.
31. Oosthuizen W, Vorster HH, Kruger A, Venter CS, Kruger HS & de Ridder JH. Impact of urbanisation on serum lipid profiles - the THUSA survey. South African Medical Journal 2002 92 723-728.
32. Vorster HH, Wissing MP, Venter CS, Kruger HS, Kruger A, Malan NT, de Ridder JH, Veldman FJ, Steyn HS, Margetts BM & MacIntyre U. The impact of urbanization on physical, physiological and mental health of Africans in the North West Province of South Africa: the THUSA study. South African Journal of Science 2000 96 505-514.
33. Seedat YK. Hypertension in black South Africans. Journal of Human Hypertension 1999 13 96-103.
34. Brewster LM, van Montfrans GA & Kleijnen J. Systematic review: antihypertensive drug therapy in black patients. Annals of Internal Medicine 2004 141 614-627.
35. Steyn K, Kazenellenbogen JM, Lombard CJ & Bourne LT. Urbanization and the risk for chronic diseases of lifestyle in the black population of the Cape Peninsula, South Africa. Journal of Cardiovascular Risk 1997 4 135-142.
36. Oelofse A, Jooste PL, Steyn K, Badenhorst CJ, Lombard C, Bourne L & Fourie J. The lipid and lipoprotein proffle of the urban black South Africa population of the Cape Peninsula - the BRISK study. South African Medical Journal 1996 86 162-166.
37. Walker AR, Adam F & Walker BF. World pandemic of obesity: the situation in Southern African populations. Public Health 2001 115 368-372.